One-Year Respiratory Outcomes of Preterm Infants Enrolled in the Nitric Oxide (to Prevent) Chronic Lung Disease Trial

Journal of Pediatrics

Volumn 153, Issue 4, 2008, Pages

  Hibbs, Anna Maria ^a   Walsh, Michele C ^a   Martin, Richard J ^a   Truog, William E ^b   Lorch, Scott A ^c   Alessandrini, Evaline ^c   Cnaan, Avital ^c   Palermo, Lisa ^d   Wadlinger, Sandra R ^c   Coburn, Christine E ^c   Ballard, Philip L ^e   Ballard, Roberta A ^e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; NITRIC OXIDE; PLACEBO; STEROID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INTENSIVE CARE; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; NEWBORN CARE; PREMATURITY; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 51449089166     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.04.033     Document Type: Article

References (38)

1. Chye J.K., and Gray P.H. Rehospitalization and growth of infants with bronchopulmonary dysplasia: a matched control study. J Paediatr Child Health 31 (1995) 105-111
2. Greenough A., Limb E., Marston L., Marlow N., Calvert S., and Peacock J. Risk factors for respiratory morbidity in infancy after very premature birth. Arch Dis Child Fetal Neonatal Ed 90 (2005) F320-F323
3. Hack M., Taylor H.G., Drotar D., Schluchter M., Cartar L., Andreias L., et al. Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s. JAMA 294 (2005) 318-325
4. Halvorsen T., Skadberg B.T., Eide G.E., Roksund O.D., Carlsen K.H., and Bakke P. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatr 93 (2004) 1294-1300
5. Korhonen P., Laitinen J., Hyodynmaa E., and Tammela O. Respiratory outcome in school-aged, very-low-birth-weight children in the surfactant era. Acta Paediatr 93 (2004) 316-321
6. Serenius F., Ewald U., Farooqi A., Holmgren P.A., Hakansson S., and Sedin G. Short-term outcome after active perinatal management at 23-25 weeks of gestation. A study from two Swedish perinatal centres. Part 3: neonatal morbidity. Acta Paediatr 93 (2004) 1090-1097
7. Walsh M.C., Yao Q., Gettner P., Hale E., Collins M., Hensman A., et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 114 (2004) 1305-1311
8. Evans M., Palta M., Sadek M., Weinstein M.R., and Peters M.E. Associations between family history of asthma, bronchopulmonary dysplasia, and childhood asthma in very low birth weight children. Am J Epidemiol 148 (1998) 460-466
9. Greenough A., Maconochie I., and Yuksel B. Recurrent respiratory symptoms in the first year of life following preterm delivery. J Perinat Med 18 (1990) 489-494
10. Elder D.E., Hagan R., Evans S.F., Benninger H.R., and French N.P. Recurrent wheezing in very preterm infants. Arch Dis Child Fetal Neonatal Ed 74 (1996) F165-F171
11. Ehrenkranz R.A., Walsh M.C., Vohr B.R., Jobe A.H., Wright L.L., Fanaroff A.A., et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116 (2005) 1353-1360
12. Ballard R.A. Inhaled nitric oxide in preterm infants-correction. N Engl J Med 357 (2007) 1444-1445
13. Ballard R.A., Truog W.E., Cnaan A., Martin R.J., Ballard P.L., Merrill J.D., et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 355 (2006) 343-353
14. Ballard R.A., Cnaan A., Truog W.E., Martin R.J., Hibbs A.M., Ballard P.L., et al. Decreased health services utilization in preterm infants treated with inhaled nitric oxide. Pediatric Academic Societies Meeting (2007), Toronto, Canada
15. Zhang B., and Schmidt B. Do we measure the right end points?. A systematic review of primary outcomes in recent neonatal randomized clinical trials. J Pediatr 138 (2001) 76-80
16. Davis P.G., Thorpe K., Roberts R., Schmidt B., Doyle L.W., and Kirpalani H. Evaluating "old" definitions for the "new" bronchopulmonary dysplasia. J Pediatr 140 (2002) 555-560
17. Walsh M.C., Wilson-Costello D., Zadell A., Newman N., and Fanaroff A. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol 23 (2003) 451-456
18. Grischkan J., Storfer-Isser A., Rosen C.L., Larkin E.K., Kirchner H.L., South A., et al. Variation in childhood asthma among former preterm infants. J Pediatr 144 (2004) 321-326
19. Kinsella J.P., Cutter G.R., Walsh W.F., Gerstmann D.R., Bose C.L., Hart C., et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 355 (2006) 354-364
20. Lorch SA, Hibbs AM, Luan X, Ballard PL, Ballard RA, Merrill JD. Early peak respiratory severity score (PRSS) as a risk factor for bronchopulmonary dysplasia (BPD). In: Pediatric Academic Societies Meeting. San Francisco, CA; 2005.
21. Ballard P.L., Gonzales L.W., Godinez R.I., Godinez M.H., Savani R.C., McCurnin D.C., et al. Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide. Pediatr Res 59 (2006) 157-162
22. Bland R.D., Albertine K.H., Carlton D.P., and MacRitchie A.J. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med 172 (2005) 899-906
23. Lin Y.J., Markham N.E., Balasubramaniam V., Tang J.R., Maxey A., Kinsella J.P., et al. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 58 (2005) 22-29
24. McCurnin D.C., Pierce R.A., Chang L.Y., Gibson L.L., Osborne-Lawrence S., Yoder B.A., et al. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 288 (2005) L450-L459
25. Tang J.R., Markham N.E., Lin Y.J., McMurtry I.F., Maxey A., Kinsella J.P., et al. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 287 (2004) L344-L351
26. Martin R.J., Mhanna M.J., and Haxhiu M.A. The role of endogenous and exogenous nitric oxide on airway function. Semin Perinatol 26 (2002) 432-438
27. Keatinge W.R., and Donaldson G.C. Changes in mortalities and hospital admissions associated with holidays and respiratory illness: implications for medical services. J Eval Clin Pract 11 (2005) 275-281
28. Griffiths C., Sturdy P., Naish J., Omar R., Dolan S., and Feder G. Hospital admissions for asthma in east London: associations with characteristics of local general practices, prescribing, and population. BMJ 314 (1997) 482-486
29. Brameld K.J., and Holman C.D. Demographic factors as predictors for hospital admission in patients with chronic disease. Aust N Z J Public Health 30 (2006) 562-566
30. Ferraro K.F., Thorpe Jr. R.J., McCabe G.P., Kelley-Moore J.A., and Jiang Z. The color of hospitalization over the adult life course: cumulative disadvantage in black and white?. J Gerontol B Psychol Sci Soc Sci 61 (2006) S299-S306
31. Watson J.P., Cowen P., and Lewis R.A. The relationship between asthma admission rates, routes of admission, and socioeconomic deprivation. Eur Respir J 9 (1996) 2087-2093
32. Alpern E.R., Stanley R.M., Gorelick M.H., Donaldson A., Knight S., Teach S.J., et al. Epidemiology of a pediatric emergency medicine research network: the PECARN Core Data Project. Pediatr Emerg Care 22 (2006) 689-699
33. Wynne J., and Hull D. Why are children admitted to hospital?. Br Med J 2 (1977) 1140-1142
34. Krug S.E., Paul R.I., Chessare J.B., Christopher N., and Satkowiak L. Hospital admissions of children from the emergency department: are decisions regarding children on public assistance different?. Pediatr Emerg Care 13 (1997) 87-91
35. Schreiber M.D., Gin-Mestan K., Marks J.D., Huo D., Lee G., and Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349 (2003) 2099-2107
36. Van Meurs K.P., Wright L.L., Ehrenkranz R.A., Lemons J.A., Ball M.B., Poole W.K., et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med 353 (2005) 13-22
37. Callanan C., Doyle L., Rickards A., Kelly E., Ford G., and Davis N. Children followed with difficulty: how do they differ?. J Paediatr Child Health 37 (2001) 152-156
38. Tin W., Fritz S., Wariyar U., and Hey E. Outcome of very preterm birth: children reviewed with ease at 2 years differ from those followed up with difficulty. Arch Dis Child Fetal Neonatal Ed 79 (1998) F83-F87